Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 581 (LINC00581)
- Target
- LINC00581
- Molecular classification
- Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA) [specific subclass of lncRNA]
01
Overview
Long intergenic non-protein coding RNA 581 (LINC00581) is a lincRNA gene that transcribes an RNA molecule longer than 200 nucleotides and does not overlap protein-coding genes[1][3]. It is believed to regulate gene expression through multiple mechanisms, including chromatin remodeling, RNA stabilization, and as a decoy for microRNAs, influencing the expression of nearby or distant genes[2][3][5]. LINC00581 has been implicated in the regulation of tumor microenvironment and may be associated with prognosis in various cancers, but there is currently no evidence that it acts as a classical drug target such as a receptor or enzyme[7][6]. Its functions are part of the broader lincRNA and lncRNA regulatory network, and it may serve as a biomarker for disease, but no direct pharmacological interventions are documented.
- Other names
- LINC00581linc-MBOAT1-4long intergenic non-protein coding RNA 581
02
Mechanism of action
no drugs target LINC00581 directly; the regulatory functions are via RNA-RNA, RNA-protein, and chromatin interactions
03
Biological functions
Regulation of gene expressionChromatin remodelingRNA stabilizationPossible enhancer-like activityActing as molecular decoy (competing endogenous RNA/ceRNA activity for miRNAs)
04
Disease associations
Cancer (roles in tumor microenvironment and disease progression have been described; LINC00581 may serve as a biomarker for certain cancers, such as papillary thyroid carcinoma and other tumors)Other: regulatory and epigenetic roles that could contribute to disease development or progression
05
Biomarkers
Putative prognostic marker in cancer settings; evidence exists for utility in thyroid and other cancers
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 581 (LINC00581).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 581 (LINC00581).